Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quetiapine for postpartum depressive disorders with or without psychotic symptoms
2006-006427-39Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of quetiapine in postpartum depression (PPD), sponsored by AstraZeneca. Primary endpoint: Change in Hamilton Rating Scale for Depression. Started Jan 2007; status: completed.
02
Drugs
quetiapine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on 2006-006427-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006427-39.